Latest Breaking News On - Highlight emerging clinical profile - Page 1 : comparemela.com

New Positive Data From Phase 3 SPROUT Trial, Studying Otezla (apremilast) in Children Ages 6-17 With Moderate to Severe Plaque Psoriasis Positive .

Davidm reeseEuropean academy of dermatologyNew positive data from phaseStudying otezlaChildren agesIsevere plaque psoriasisResults fromInvestigating clinical efficacyPatients with moderateSevere genital psoriasisRocatinlimab phaseHighlight emerging clinical profileSevere atopicEuropean academyPresentation timesPediatric patients